Singapore - Straits Ti (SINGAPO.NDX)

Close: 5 695.93 (+6.18), Sep 11, 2026
Positive

Automatic technical analysis. Medium term, Sep 11, 2026

Investors have paid higher prices over time to buy Singapore - Straits Times and the index is in a rising trend channel in the medium long term. This signals increasing optimism among investors and indicates continued rise. The index has marginally broken down through support at points 5760. An established break predicts a further decline. The index is assessed as technically positive for the medium long term.

Recommendation one to six months: Positive

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.52%237.58+0.11%
5 days80.281.92%266.84-1.83%
22 days-1.425.37%293.13-0.43%
66 days-5.6211.17%263.10+14.19%

More analyses of Singapore - Straits Times

chart Singapore - Straits Times (SINGAPO) Candlesticks 22 Days
Candlesticks
chart Singapore - Straits Times (SINGAPO) Short term
Short term: Positive
chart Singapore - Straits Times (SINGAPO) Medium term
Medium term: Positive
chart Singapore - Straits Times (SINGAPO) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.